Work

800P Response to chemotherapy following PARP inhibition in UK ovarian cancer (OC) patients

Year: 2023

Type: article

Source: Annals of Oncology

DOI: 10.1016/j.annonc.2023.09.1978

Authors: S. Howlett, A.M. Berner, K. Connolly, A. Orosco Ttamina, A. D'Angelo, G. Gullick, H. Abdallah, J. Wood, U. Mukherjee, M. Azhar, D. Lee, P. Mahalingam, L. Tookman, L.H. Cossar, R. Miller, M. Hall, S. Khalique

Institutions: Wexham Park Hospital, Barts Cancer Institute, Edinburgh Cancer Research, St Bartholomew's Hospital, Barts Health NHS Trust, Royal United Hospital, Royal United Hospital Bath NHS Trust, University Hospitals of Leicester NHS Trust, University College London Hospitals NHS Foundation Trust, Imperial College London, Mount Vernon Cancer Centre

Language: English

Topic: PARP inhibition in cancer therapy

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

Funders: National Natural Science Foundation of China, Peking Union Medical College Hospital

Award: G3007113039

OpenAlex ID: W4387825382

FWCI: 0.122

Cites:

Cited by: 1

Related to: 10